There are, however, an assortment of metrics and events that have strongly correlated with directional moves in the stock ...

Donald Trump's social media posts have severely grown more aggressive in voicing his two cents on the 'America First' agenda ...

The Dow Jones Industrial Average, the S&P 500, and the Nasdaq Composite rose Friday as the stock market bet on Fed rates cuts and the tech rally rolled on.

Is Trump Media similar to Kodak entering the pharmaceutical business, or like a SPAC merging with an EV start-up?

Discover how Oracle's TikTok deal, Nvidia's potential chip sales to China, and Micron's strong revenue forecast helped boost ...

Dow Jones stock MerckMRK and eight other bellwether pharmaceutical companies struck drug-pricing agreements with the Trump ...

US stocks rose as 2025's last full week of trading drew to a close, with Wall Street weighing catch-up jobs and inflation ...

The Trump administration on Friday announced deals with nine drugmakers aimed at lowering pharmaceutical prices, bringing its total number of drug-pricing agreements to 14.

After President Donald Trump on Thursday signed an executive order to reclassify cannabis, Wall Street is now focused on the when the change will actually happen, as the marijuana industry waits for ...

Major stock indexes jumped for a second straight session Friday, with AI-related shares again leading the charge as risk returned to the market.

Refined product futures were mixed. The NYMEX February RBOB contract was up 0.75ct to $1.7145/gal and January RBOB was 0.65ct higher at $1.7075/gal. The February ULSD contract was trading 1.15ct lower ...

The Nasdaq Composite rose 0.5%, while the S&P 500 added 0.4%. The Dow Jones Industrial Average advanced 176 points, or 0.4%.